WOLVERINE TRADING, LLC - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q1 2023$33
-57.1%
11,700
-20.4%
0.00%
Q4 2022$77
-99.9%
14,700
-30.2%
0.00%
Q3 2022$82,000
+28.1%
21,066
+26.9%
0.00%
Q2 2022$64,000
-34.0%
16,600
-14.9%
0.00%
Q1 2022$97,000
-55.1%
19,500
-50.8%
0.00%
Q4 2021$216,000
-21.5%
39,605
-10.6%
0.00%
Q3 2021$275,000
+212.5%
44,317
+216.6%
0.00%
Q2 2021$88,00014,0000.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,058,035$2,9310.15%
Gradient Capital Advisors, LLC 26,808$74,2580.03%
WEST PACES ADVISORS INC. 1,665$4,6120.00%
DIMENSIONAL FUND ADVISORS LP 28,652$79,3660.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$48,4300.00%
CITIGROUP INC 7$190.00%
MORGAN STANLEY 533$1,4760.00%
NATIONAL BANK OF CANADA /FI/ 2,255$6,2510.00%
WOLVERINE TRADING, LLC 11,700$330.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders